SteadyMed’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

SteadyMed develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension. Read more

SteadyMed develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension. Read more

Jonathan Rigby's photo - President & CEO of SteadyMed

President & CEO

Jonathan Rigby

CEO Approval Rating

69/100

Founded:

2005

Status:

Est. Annual Revenue
Est. Employees
Sector

Update Industry

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

CeQur SA has been one of SteadyMed's top competitors. CeQur SA's headquarters is in Horw, Lucerne, and was founded in 2008. CeQur SA is in the Health Care Equipment industry. CeQur SA generates 614% of SteadyMed's revenue.

Medipacs is one of SteadyMed's top rivals. Medipacs is a Private company that was founded in Tucson, Arizona in 2004. Medipacs operates in the Health Care Technology industry. Medipacs has 15 more employees vs. SteadyMed.

scPharmaceuticals is perceived as one of SteadyMed's biggest rivals. scPharmaceuticals was founded in 2013, and is headquartered in Burlington, Massachusetts. scPharmaceuticals operates in the Health Care Technology industry. scPharmaceuticals generates $6.4M more revenue vs. SteadyMed.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 26 a good estimate for SteadyMed's Employee count?

Acquisitions

No recent acquisitions found related to SteadyMed

SteadyMed Funding History

$19.6M$71.8M$103.8M$138.8M

Since SteadyMed was founded in 2005, it has participated in 6 rounds of funding. In total SteadyMed has raised $138.8M. SteadyMed's last funding round was on May 2017 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
May 2017
$5M
-
Private Placement
Apr 2017
$30M
Private Placement
Jul 2016
$32M
IPO
Mar 2015
$40M

Equity
Jan 2015
$12.2M

Total Funding: $138.8M

Since SteadyMed was founded in 2005, it has participated in 6 rounds of funding. In total SteadyMed has raised $138.8M. SteadyMed's last funding round was on May 2017 for a total of $5.0M

Investments

No recent investments found related to SteadyMed

SteadyMed News

August 2, 2018Market Exclusive

SteadyMed Ltd. (NASDAQ:STDY) Files An 8-K Submission of Matters to a Vote of Security Holders

On July30, 2018, SteadyMed Ltd. (the “Company”) held an extraordinary general meeting of its sharehol... See more »
May 15, 2018PharmiWeb

SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results

SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial ResultsSAN RAMON, Calif.... See more »
May 8, 20184-traders

Notifies Investors of an Investigation into SteadyMed Ltd. in Connection with the Sale of the Company to United Therapeutics Corporation - STDY

(4-traders.com) The Law Offices of Vincent Wong are investigating the Board of Directors of SteadyMed... See more »
May 3, 20184-traders

Brodsky & Smith, LLC Announces an Investigation of SteadyMed Ltd.- STDY

(4-traders.com) BALA CYNWYD, PA / ACCESSWIRE / May 3, 2018 / Law office of Brodsky & Smith, LLC annou... See more »
May 3, 20184-traders

Brower Piven Commences an Investigation into the Proposed Sale of SteadyMed Ltd.�and Encourages Shareholders to Contact the Firm for Additional Information

(4-traders.com) The securities litigation law firm of Brower Piven, A Professional Corporation, has c... See more »
May 1, 2018The Business Journals

United Therapeutics acquiring rival drugmaker

United Therapeutics Corp. has reached a deal to acquire Israel-based SteadyMed Therapeutics Inc. in a... See more »
April 30, 2018The Business Journals

Taking out potential competition, drug maker says it will buy East Bay rival

An East Bay company that planned to grab part of the market for drugs controlling high blood pressure... See more »

SteadyMed Press Releases

December 7, 2016Blackbird

SteadyMed Hires Pulmonary Hypertension Veteran to Lead Patient Advocacy and Community Relations

SAN RAMON, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) - SteadyMed Therapeutics Ltd. (NASDAQ:STDY), a spec... See more »
December 5, 2016Blackbird

SteadyMed Provides Update on IPR Hearing

SAN RAMON, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) - SteadyMed Therapeutics Ltd. (NASDAQ:STDY), a spec... See more »
November 14, 2016Blackbird

SteadyMed Provides Corporate Update and Reports Third Quarter 2016 Financial Results

SAN RAMON, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) - SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmac... See more »

Social Statistics

Headquarters

2603 Camino Ramon Suite 350

San Ramon, California94583

925-272-4999

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

SteadyMed develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension. SteadyMed was founded in 2005. SteadyMed's headquarters is located in San Ramon, California, USA 94583. It has raised 138....

CEO

SteadyMed's President & CEO, Jonathan Rigby, currently has an approval rating of 69%. SteadyMed's primary competitors are CeQur SA, Medipacs & scPharmaceuticals.

Website

steadymed.com

Frequently Asked Questions about SteadyMed

  1. When was SteadyMed founded?

    SteadyMed was founded in 2005
  2. Who is SteadyMed's CEO?

    SteadyMed's CEO is Jonathan Rigby
  3. How much revenue does SteadyMed generate?

    SteadyMed generates $1.1M in revenue
  4. How much funding does SteadyMed have?

    SteadyMed has historically raised $138.8M in funding
  1. Where is SteadyMed's headquarters?

    SteadyMed's headquarters is in San Ramon California, USA
  2. How many employees does SteadyMed have?

    SteadyMed has 26 employees
  3. Who are SteadyMed's competitors?

    SteadyMed's top competitors are CeQur SA, Medipacs, scPharmaceuticals